Data as of Dec 19
| +0.51 / +0.84%|
The 19 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 58.00, with a high estimate of 66.00 and a low estimate of 36.00. The median estimate represents a -5.38% decrease from the last price of 61.30.
The current consensus among 22 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.